Prostate Cancer
Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy.
February 3, 2025
Shifting tides: A survey analysis of urologists' evolving attitudes toward focal therapy for prostate cancer.
February 3, 2025
Comparison of standard-dose and reduced-dose treatment of metastatic prostate cancer with enzalutamide, apalutamide or darolutamide: a rapid review.
February 3, 2025
Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrence.
January 31, 2025
PARP inhibitor-based treatment in metastatic, castration-resistant prostate cancer (mCRPC): A systematic review and meta-analysis.
January 31, 2025
Transcriptome-Wide Association Study Identified Novel Blood Tissue Gene Biomarkers for Prostate Cancer Risk.
January 31, 2025
The gut microbiota associated with high-Gleason prostate cancer.
January 31, 2025
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis.
January 31, 2025
Firmicutes in Gut Microbiota Correlate with Blood Testosterone Levels in Elderly Men.
January 31, 2025
Gut Microbiota-Derived Short-Chain Fatty Acids Promote Prostate Cancer Growth via IGF1 Signaling.
January 31, 2025
Gut Microbiota Dysbiosis Accelerates Prostate Cancer Progression Through Increased LPCAT1 Expression and Enhanced DNA Repair Pathways.
January 31, 2025
Prostate Artery Embolization in the Setting of Prostate Cancer: Review and Opinion.
January 30, 2025
External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study.
January 30, 2025